Harmony Biosciences Holdings, Inc. (HRMY)
USD 30.32
(1.54%)
USD 30.32
(1.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 344.45 Million USD | 27.09% |
| 2022 | 271.03 Million USD | 9.76% |
| 2021 | 246.93 Million USD | -25.15% |
| 2020 | 329.89 Million USD | 178.89% |
| 2019 | 118.28 Million USD | 1425.51% |
| 2018 | 7.75 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 331.59 Million USD | -3.73% |
| 2024 Q3 | 331.33 Million USD | 3.61% |
| 2024 Q2 | 319.8 Million USD | -3.56% |
| 2023 Q3 | 296.43 Million USD | 7.79% |
| 2023 Q2 | 275.01 Million USD | 1.09% |
| 2023 FY | 344.45 Million USD | 27.09% |
| 2023 Q1 | 272.05 Million USD | 0.38% |
| 2023 Q4 | 344.45 Million USD | 16.2% |
| 2022 Q2 | 258.5 Million USD | 3.61% |
| 2022 Q1 | 249.5 Million USD | 1.04% |
| 2022 FY | 271.03 Million USD | 9.76% |
| 2022 Q4 | 271.03 Million USD | -9.53% |
| 2022 Q3 | 299.58 Million USD | 15.89% |
| 2021 Q1 | 229.37 Million USD | -30.47% |
| 2021 FY | 246.93 Million USD | -25.15% |
| 2021 Q4 | 246.93 Million USD | 3.29% |
| 2021 Q3 | 239.07 Million USD | 2.54% |
| 2021 Q2 | 233.14 Million USD | 1.64% |
| 2020 Q2 | 218.17 Million USD | 2.53% |
| 2020 Q3 | 225.52 Million USD | 3.37% |
| 2020 Q4 | 329.89 Million USD | 46.28% |
| 2020 FY | 329.89 Million USD | 178.89% |
| 2020 Q1 | 212.78 Million USD | 79.88% |
| 2019 Q4 | 118.28 Million USD | 0.0% |
| 2019 FY | 118.28 Million USD | 1425.51% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 7.75 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Absci Corporation | 58.3 Million USD | -490.793% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 2.381% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 91.496% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -10578.247% |
| Apollomics, Inc. | 14.15 Million USD | -2333.802% |
| 180 Life Sciences Corp. | 5.38 Million USD | -6293.96% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -6478.61% |
| Bicycle Therapeutics plc | 224.41 Million USD | -53.493% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1152.066% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -164.539% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -574.043% |
| Chimerix, Inc. | 19.74 Million USD | -1644.523% |
| CRISPR Therapeutics AG | 346.76 Million USD | 0.667% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -73.685% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -287.635% |
| Fortress Biotech, Inc. | 165.93 Million USD | -107.58% |
| Fortress Biotech, Inc. | 165.93 Million USD | -107.58% |
| Gritstone bio, Inc. | 125.91 Million USD | -173.554% |
| Allakos Inc. | 74.79 Million USD | -360.546% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -34.042% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -400.961% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 71.548% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2279.99% |
| Innoviva, Inc. | 568.55 Million USD | 39.415% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -48760.185% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3125.182% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1210.017% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -26412.094% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2519.437% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1299.886% |
| ImmuCell Corporation | 18.81 Million USD | -1730.75% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1120.35% |
| Incyte Corporation | 1.59 Billion USD | 78.367% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -519.578% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -85180.807% |
| Mustang Bio, Inc. | 17.61 Million USD | -1855.026% |
| MiMedx Group, Inc. | 96.33 Million USD | -257.579% |
| MEI Pharma, Inc. | 8.35 Million USD | -4022.753% |
| MacroGenics, Inc. | 154.2 Million USD | -123.372% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -19500.397% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2057.975% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -11102.375% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -123.465% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 50.62% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -303.542% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -5550.525% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -6720.911% |
| NextCure, Inc. | 14.99 Million USD | -2196.833% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1167.827% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -8421.92% |
| Onconetix, Inc. | 23.18 Million USD | -1385.948% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5058.844% |
| Opthea Limited | 264.6 Million USD | -30.179% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -512.585% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2745.639% |
| PDS Biotechnology Corporation | 33.25 Million USD | -935.673% |
| Precigen, Inc. | 41.64 Million USD | -727.144% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2789.247% |
| Prime Medicine, Inc. | 60.78 Million USD | -466.726% |
| PureTech Health plc | 125.58 Million USD | -174.286% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -366.951% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 95.153% |
| Replimune Group, Inc. | 113.21 Million USD | -204.252% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6089.803% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -136.141% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -9661.038% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -31.273% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5113.281% |
| Sesen Bio, Inc. | 30.98 Million USD | -1011.722% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -317.862% |
| Solid Biosciences Inc. | 38.45 Million USD | -795.668% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -486.967% |
| SciSparc Ltd. | 1.59 Million USD | -21495.987% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -7.278% |
| TG Therapeutics, Inc. | 169.08 Million USD | -103.718% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -603.948% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -23754.294% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 41.429% |
| UroGen Pharma Ltd. | 243.52 Million USD | -41.447% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -457.066% |
| XOMA Corporation | 145.58 Million USD | -136.609% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -176.37% |
| AbCellera Biologics Inc. | 335.77 Million USD | -2.585% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3424.207% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2326.601% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -879.205% |
| Precision BioSciences, Inc. | 140.92 Million USD | -144.434% |
| Dyadic International, Inc. | 2.34 Million USD | -14616.248% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -8234.285% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2018.035% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3748.67% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1007.896% |
| IGM Biosciences, Inc. | 220.17 Million USD | -56.445% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -258.215% |
| Acelyrin, Inc. | 86.35 Million USD | -298.893% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -600.456% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -163.533% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -9661.486% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -128.284% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -127.346% |
| Senti Biosciences, Inc. | 52.57 Million USD | -555.221% |
| Mesoblast Limited | 188.79 Million USD | -82.447% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -90.53% |
| ChromaDex Corporation | 26.5 Million USD | -1199.442% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3925.339% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -26.505% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -21115.361% |
| Seer, Inc. | 39.36 Million USD | -775.031% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 0.899% |
| Novavax, Inc. | 2.57 Billion USD | 86.609% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -4376.929% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -149.968% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1769.503% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -262.292% |
| Celcuity Inc. | 51.45 Million USD | -569.496% |
| ContextLogic Inc. | 206 Million USD | -67.212% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 29.212% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -381.891% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 95.501% |
| Amarin Corporation plc | 279.58 Million USD | -23.202% |
| AnaptysBio, Inc. | 364.28 Million USD | 5.444% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2629.229% |
| Aptorum Group Limited | 5.25 Million USD | -6452.657% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 53.779% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 27.997% |
| Ardelyx, Inc. | 130.76 Million USD | -163.42% |
| Celularity Inc. | 102.92 Million USD | -234.654% |
| Omeros Corporation | 403.25 Million USD | 14.58% |
| Humacyte, Inc. | 114.67 Million USD | -200.371% |
| Immunocore Holdings plc | 228.15 Million USD | -50.973% |
| IO Biotech, Inc. | 17.55 Million USD | -1862.041% |
| GT Biopharma, Inc. | 6.63 Million USD | -5093.065% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1873.734% |
| Summit Therapeutics Inc. | 125.25 Million USD | -174.999% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -17510.225% |
| Pulmatrix, Inc. | 15.96 Million USD | -2057.84% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -37.339% |
| Evogene Ltd. | 17.99 Million USD | -1814.708% |
| CorMedix Inc. | 11.91 Million USD | -2790.331% |
| BioLineRx Ltd. | 50.7 Million USD | -579.374% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -3577.335% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -5992.253% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 87.344% |
| scPharmaceuticals Inc. | 57.26 Million USD | -501.554% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1430.848% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -200.017% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3125.182% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5113.281% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -666.054% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -11901.951% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -4965.529% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -400.83% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1729.682% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -636.978% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2680.557% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1208.234% |
| bluebird bio, Inc. | 424.62 Million USD | 18.88% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 81.775% |
| DBV Technologies S.A. | 42.8 Million USD | -704.804% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -169.546% |
| Galecto, Inc. | 5.89 Million USD | -5742.198% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -3533.885% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1155.443% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -30.283% |
| GlycoMimetics, Inc. | 6.9 Million USD | -4890.616% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -36.311% |
| ADMA Biologics, Inc. | 193.97 Million USD | -77.577% |
| Clene Inc. | 38.95 Million USD | -784.332% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -81.042% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2078.901% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3020.161% |
| Soligenix, Inc. | 7.27 Million USD | -4634.853% |
| Century Therapeutics, Inc. | 175.94 Million USD | -95.779% |
| Kura Oncology, Inc. | 51.66 Million USD | -566.749% |
| Surrozen, Inc. | 8.14 Million USD | -4129.048% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -184.012% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5108.097% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -36.365% |
| Autolus Therapeutics plc | 263.9 Million USD | -30.522% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3186.167% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -634.463% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -374.673% |
| GRI Bio, Inc. | 2.69 Million USD | -12671.821% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -42447.231% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -855.283% |
| INmune Bio, Inc. | 18.86 Million USD | -1726.19% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -34.302% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1192.915% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -12571.249% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -9504.185% |
| Jaguar Health, Inc. | 45.86 Million USD | -651.005% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -10400.856% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -489.267% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -589.878% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -30.114% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 58.148% |
| Verastem, Inc. | 71.18 Million USD | -383.888% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -792.882% |
| Histogen Inc. | 5.69 Million USD | -5946.27% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -7754.241% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -8.592% |
| Surrozen, Inc. | 8.14 Million USD | -4129.048% |
| Organovo Holdings, Inc. | 2.74 Million USD | -12434.789% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -109648.995% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -41557.566% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -171.814% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3085.399% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -13110.987% |
| Kronos Bio, Inc. | 54.2 Million USD | -535.516% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2334.662% |
| Synaptogenix, Inc. | 5.52 Million USD | -6129.459% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5081.348% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -51.855% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -102.493% |
| Exelixis, Inc. | 678.44 Million USD | 49.229% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -109.975% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 42.031% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2247.07% |
| ESSA Pharma Inc. | 3.49 Million USD | -9755.479% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -6669.134% |
| Avid Bioservices, Inc. | 275.66 Million USD | -24.953% |
| Insmed Incorporated | 1.66 Billion USD | 79.272% |
| MediWound Ltd. | 27.18 Million USD | -1166.988% |
| OmniAb, Inc. | 87.4 Million USD | -294.114% |
| Alector, Inc. | 487.66 Million USD | 29.367% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 14.624% |
| Zai Lab Limited | 240.17 Million USD | -43.418% |
| AlloVir, Inc. | 45.01 Million USD | -665.203% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 45.329% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1025.747% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1078.554% |
| Immunic, Inc. | 25.36 Million USD | -1257.837% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -397.51% |
| Veracyte, Inc. | 93.71 Million USD | -267.541% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -13063.892% |
| FibroGen, Inc. | 585.72 Million USD | 41.192% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1881.568% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -309.94% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -52643.632% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -5990.683% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4101.708% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -309.959% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 86.845% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1095.115% |
| XBiotech Inc. | 8.39 Million USD | -4002.132% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2247.07% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -810.97% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2295.549% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -547.717% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 5.136% |
| Agenus Inc. | 462.29 Million USD | 25.49% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1181.268% |
| Theravance Biopharma, Inc. | 169 Million USD | -103.815% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 71.664% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 31.167% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 64.58% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -5611.323% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -164.281% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -92646.786% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -6583.236% |
| Lantern Pharma Inc. | 2.73 Million USD | -12472.846% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -710.962% |
| Ainos, Inc. | 7.39 Million USD | -4558.448% |
| Pluri Inc. | 34.11 Million USD | -909.78% |
| Prothena Corporation plc | 135.01 Million USD | -155.12% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -41.691% |
| Rallybio Corporation | 9.43 Million USD | -3550.445% |
| Kodiak Sciences Inc. | 213.59 Million USD | -61.269% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1309.106% |
| MeiraGTx Holdings plc | 319.99 Million USD | -7.646% |
| Annexon, Inc. | 47.11 Million USD | -631.05% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -257.423% |
| Moderna, Inc. | 4.57 Billion USD | 92.466% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -6965.764% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -348.861% |
| Blueprint Medicines Corporation | 918.64 Million USD | 62.504% |
| Immix Biopharma, Inc. | 3.72 Million USD | -9155.134% |
| CalciMedica, Inc. | 4.02 Million USD | -8451.539% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -176.66% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -301.384% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -51.446% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -23.997% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2083.833% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -578.25% |
| Nutriband Inc. | 1.07 Million USD | -31826.03% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3139.5% |
| Vor Biopharma Inc. | 59.1 Million USD | -482.796% |
| Roivant Sciences Ltd. | 773.95 Million USD | 55.494% |
| Alkermes plc | 933.53 Million USD | 63.102% |
| ProKidney Corp. | 29.21 Million USD | -1078.998% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -378.551% |
| Arcellx, Inc. | 339.75 Million USD | -1.385% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 81.764% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -130.469% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -289.475% |
| Atai Life Sciences N.V. | 49.16 Million USD | -600.655% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1005.716% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1817.693% |
| MediciNova, Inc. | 3.89 Million USD | -8751.376% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1784.436% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -22798.99% |
| GeoVax Labs, Inc. | 3.51 Million USD | -9686.013% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 13.292% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1022.372% |
| RenovoRx, Inc. | 4.46 Million USD | -7612.853% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1003.99% |
| Geron Corporation | 146.12 Million USD | -135.724% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1708.358% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -974.343% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -366.806% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -293.74% |
| Royalty Pharma plc | 6.29 Billion USD | 94.53% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -920.006% |
| Imunon, Inc. | 8.53 Million USD | -3937.969% |
| BioAtla, Inc. | 48.98 Million USD | -603.172% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -163.741% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2323.187% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -82.102% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1085.694% |
| 89bio, Inc. | 59.96 Million USD | -474.448% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -923.187% |
| aTyr Pharma, Inc. | 31.59 Million USD | -990.154% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -457.165% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -611.657% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4122.3% |
| Akari Therapeutics, Plc | 4.58 Million USD | -7414.311% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1842.443% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 79.117% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -152.684% |
| Liquidia Corporation | 73.13 Million USD | -370.967% |
| Entera Bio Ltd. | 1.37 Million USD | -24878.68% |
| GH Research PLC | 6.7 Million USD | -5040.367% |
| Vericel Corporation | 127.7 Million USD | -169.728% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -797.418% |
| Xencor, Inc. | 283.55 Million USD | -21.476% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -11436.956% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -12571.249% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -9068.074% |
| Vaxcyte, Inc. | 167.44 Million USD | -105.708% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -834.067% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -232.711% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -85180.807% |
| Portage Biotech Inc. | 4.45 Million USD | -7640.584% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -22798.99% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1394.386% |
| OncoCyte Corporation | 49.29 Million USD | -598.722% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -8226.619% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -43092.841% |
| Purple Biotech Ltd. | 10 Million USD | -3342.839% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1286.978% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5085.248% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -111.341% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -5853.267% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2736.43% |
| United Therapeutics Corporation | 1.18 Billion USD | 70.863% |
| HilleVax, Inc. | 78.9 Million USD | -336.523% |
| Silo Pharma, Inc. | 1.56 Million USD | -21850.079% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -25691.052% |
| Pharming Group N.V. | 244.07 Million USD | -41.128% |
| Tharimmune, Inc. | 1.81 Million USD | -18877.811% |
| Genprex, Inc. | 3.25 Million USD | -10484.941% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1502.792% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1170.165% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -617.288% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -167111.65% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -95969.703% |
| OKYO Pharma Limited | 7.42 Million USD | -4541.735% |
| Savara Inc. | 37.19 Million USD | -826.156% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1087.165% |
| Curis, Inc. | 57.61 Million USD | -497.889% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -778.719% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1554.527% |
| BeiGene, Ltd. | 2.23 Billion USD | 84.579% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1519.141% |
| Erasca, Inc. | 78.61 Million USD | -338.178% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -52468.477% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -52468.477% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -4824.317% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -20700.483% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1917.903% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -844.854% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -519.135% |
| Adicet Bio, Inc. | 37.12 Million USD | -827.953% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 44.236% |
| Aditxt, Inc. | 28.53 Million USD | -1107.281% |
| Adagene Inc. | 45.16 Million USD | -662.588% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -190522.077% |
| Quantum-Si incorporated | 26.63 Million USD | -1193.44% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -11221.71% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -199.629% |
| Compugen Ltd. | 55.77 Million USD | -517.581% |
| Generation Bio Co. | 171.63 Million USD | -100.697% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2882.303% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -723.447% |
| Invivyd, Inc. | 51.71 Million USD | -566.092% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -274.502% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -5195.045% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -356.257% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -33637.12% |
| 2seventy bio, Inc. | 310.12 Million USD | -11.07% |
| Instil Bio, Inc. | 99.8 Million USD | -245.143% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -853.304% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -25174.83% |
| GeoVax Labs, Inc. | 3.51 Million USD | -9686.013% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2728.124% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2724.614% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -551.873% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 6.867% |
| Evaxion Biotech A/S | 17.61 Million USD | -1855.195% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -114.042% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -124.861% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1495.073% |
| Cingulate Inc. | 10.36 Million USD | -3224.587% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -12425.673% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -823.673% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1286.197% |
| Clearmind Medicine Inc. | 3.61 Million USD | -9441.696% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -632.215% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1413.445% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1616.188% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -46.444% |
| ImmunityBio, Inc. | 1.09 Billion USD | 68.41% |
| Korro Bio, Inc. | 51.75 Million USD | -565.59% |
| Kineta, Inc. | 7.22 Million USD | -4669.538% |
| BioVie Inc. | 9.7 Million USD | -3450.313% |
| Codexis, Inc. | 49.94 Million USD | -589.657% |
| Celularity Inc. | 102.92 Million USD | -234.654% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -206.458% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -257.888% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -99686.207% |
| Cibus, Inc. | 206.11 Million USD | -67.117% |
| IN8bio, Inc. | 8.77 Million USD | -3826.767% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -284.691% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2416.298% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 86.769% |
| Eyenovia, Inc. | 19.78 Million USD | -1641.411% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -94.513% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4384.52% |
| Elevation Oncology, Inc. | 34.28 Million USD | -904.772% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1329.337% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2795.075% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -40.285% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -3501.966% |
| Moolec Science SA | 13.94 Million USD | -2370.041% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -698.239% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -581.659% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -765.99% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -4031.654% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -116900.333% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -13900.671% |
| Humacyte, Inc. | 114.67 Million USD | -200.371% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1201.651% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -28700.669% |
| Genelux Corporation | 8.42 Million USD | -3990.926% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -4924.154% |
| Notable Labs, Ltd. | 4.42 Million USD | -7680.8% |
| Immunovant, Inc. | 48.95 Million USD | -603.618% |
| Quantum-Si incorporated | 26.63 Million USD | -1193.44% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -11000.741% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -366.357% |
| Acasti Pharma Inc. | 11.55 Million USD | -2880.497% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1423.62% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1385.749% |
| PepGen Inc. | 34.63 Million USD | -894.646% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -4832.073% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3925.339% |
| Immuneering Corporation | 12 Million USD | -2768.469% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -109648.995% |
| Belite Bio, Inc | 4.21 Million USD | -8079.91% |
| XOMA Corporation | 145.58 Million USD | -136.609% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -14086.82% |
| Bionomics Limited | 10.15 Million USD | -3290.742% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1403.321% |
| uniQure N.V. | 624.01 Million USD | 44.8% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -190522.077% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -102.402% |
| Forte Biosciences, Inc. | 3.66 Million USD | -9295.963% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -132086.674% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -5005.321% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4384.52% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1881.568% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3159.425% |
| Altimmune, Inc. | 16.54 Million USD | -1982.438% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -6967.214% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1403.321% |
| Peak Bio, Inc. | 20.75 Million USD | -1559.76% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -211.829% |
| Benitec Biopharma Inc. | 4.96 Million USD | -6841.878% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -118.227% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -358.212% |
| Zura Bio Limited | 21.29 Million USD | -1517.772% |
| PolyPid Ltd. | 17.46 Million USD | -1871.926% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -358.212% |
| argenx SE | 444.95 Million USD | 22.586% |
| Immunome, Inc. | 28.65 Million USD | -1101.954% |
| Verona Pharma plc | 58.84 Million USD | -485.401% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2279.99% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2218.164% |
| CervoMed Inc. | 2.59 Million USD | -13170.014% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2604.585% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3169.635% |
| Moolec Science SA | 13.94 Million USD | -2370.041% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -14598.332% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2781.03% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2615.673% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -784.854% |
| Achilles Therapeutics plc | 19.08 Million USD | -1704.663% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1413.445% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2273.758% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 14.159% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -960.746% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2539.692% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -6457.32% |
| Beam Therapeutics Inc. | 478.38 Million USD | 27.996% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 13.443% |
| AEON Biopharma, Inc. | 159.88 Million USD | -115.434% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1165.08% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1226.821% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -4430.995% |
| NeurAxis, Inc. | 1.91 Million USD | -17908.521% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -75.978% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2483.485% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1360.302% |
| Palisade Bio, Inc. | 2.73 Million USD | -12475.977% |
| Nutriband Inc. | 1.07 Million USD | -31826.03% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -79.351% |
| Neurogene Inc. | 36.54 Million USD | -842.45% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -13988.18% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -622.888% |
| Athira Pharma, Inc. | 30.05 Million USD | -1046.009% |
| HCW Biologics Inc. | 15.05 Million USD | -2188.449% |
| XOMA Corporation | 145.58 Million USD | -136.609% |
| Nektar Therapeutics | 267.04 Million USD | -28.988% |
| Arvinas, Inc. | 644.6 Million USD | 46.563% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1842.443% |
| Merus N.V. | 102.15 Million USD | -237.203% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -135.365% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -262.128% |
| Rezolute, Inc. | 11.73 Million USD | -2835.538% |
| Clene Inc. | 38.95 Million USD | -784.332% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -11997.296% |
| BeyondSpring Inc. | 48.26 Million USD | -613.617% |
| Synlogic, Inc. | 32.89 Million USD | -947.138% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2257.189% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -20980.539% |
| Peak Bio, Inc. | 20.75 Million USD | -1559.76% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -442.801% |
| Krystal Biotech, Inc. | 39.71 Million USD | -767.341% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 8.546% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -245.947% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -79501.411% |
| MannKind Corporation | 721.36 Million USD | 52.249% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1442.225% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -16412.752% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -235.76% |
| Gossamer Bio, Inc. | 249.14 Million USD | -38.254% |
| CohBar, Inc. | 1.03 Million USD | -33224.626% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3122.528% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1708.358% |
| Legend Biotech Corporation | 589.93 Million USD | 41.611% |
| Mural Oncology plc | 37.92 Million USD | -808.184% |
| Disc Medicine, Inc. | 22.87 Million USD | -1405.819% |
| Champions Oncology, Inc. | 28.03 Million USD | -1128.664% |
| REGENXBIO Inc. | 262.22 Million USD | -31.357% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -10153.644% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2648.173% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2464.514% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1524.409% |
| Vaxart, Inc. | 34.02 Million USD | -912.361% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1589.399% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1107.267% |
| Cellectis S.A. | 249.57 Million USD | -38.017% |
| Longeveron Inc. | 5.33 Million USD | -6354.113% |
| Repare Therapeutics Inc. | 41.81 Million USD | -723.683% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 85.679% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -470.594% |
| Revolution Medicines, Inc. | 262.39 Million USD | -31.273% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -16248.173% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3893.23% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2818.871% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2352.866% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -15913.761% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 93.311% |
| Denali Therapeutics Inc. | 122.96 Million USD | -180.13% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6089.803% |
| Veru Inc. | 32.81 Million USD | -949.764% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -4914.646% |
| Cingulate Inc. | 10.36 Million USD | -3224.587% |
| Passage Bio, Inc. | 39.26 Million USD | -777.327% |
| Context Therapeutics Inc. | 4.19 Million USD | -8117.543% |
| Exicure, Inc. | 8.54 Million USD | -3929.196% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1067.331% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3184.913% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1462.797% |
| Nuvalent, Inc. | 31.82 Million USD | -982.412% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -5314.59% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -446.565% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1813.644% |
| OmniAb, Inc. | 87.4 Million USD | -294.114% |
| Anew Medical, Inc. | 8.24 Million USD | -4079.379% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -799.619% |
| Lipocine Inc. | 2.63 Million USD | -12989.079% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1211.114% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -756.6% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1192.915% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -299.814% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -6277.634% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -316.276% |
| Ocugen, Inc. | 23.98 Million USD | -1336.251% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -642.25% |
| Q32 Bio Inc. | 233.12 Million USD | -47.754% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -3699.426% |
| Alumis Inc. Common Stock | 53.5 Million USD | -543.819% |
| Equillium, Inc. | 27.95 Million USD | -1132.092% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -66.732% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -6021.85% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -5516.465% |
| Dominari Holdings Inc. | 4.63 Million USD | -7331.629% |
| Edesa Biotech, Inc. | 1.84 Million USD | -18603.795% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1065.002% |
| Bio-Techne Corporation | 744.34 Million USD | 53.723% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -173.163% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -748.937% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1089.543% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -272.949% |
| Nkarta, Inc. | 105.6 Million USD | -226.189% |
| BioCardia, Inc. | 4.59 Million USD | -7404.488% |
| Iterum Therapeutics plc | 32.66 Million USD | -954.608% |